Nine Masts Capital »

C4 Therapeutics shares owned by Nine Masts Capital

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 12k 1.91

More positions owned by Nine Masts Capital

Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Norfolk Southern (NSC)
Fox Corp Cl B Com (FOX)
Invesco Qqq Tr Unit Ser 1 (Principal) (QQQ)
Cyberark Software SHS (CYBR)
Nio Note 4.625%10/1 (Principal)
Qorvo (QRVO)
Ase Technology Hldg Sponsored Ads (ASX)
GSK Sponsored Adr (GSK)
Zillow Group Cl C Cap Stk (Z)
EXACT Sciences Corporation (EXAS)
Ryanair Holdings Sponsored Adr (RYAAY)
Jd.com Spon Ads Cl A (JD)

View all positions for Nine Masts Capital

Top funds holding C4 Therapeutics

Point72 Asset Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
OrbiMed Advisors
Vanguard Group
Daniel D. Thurber
Soleus Capital Management
Millennium Management
Silverarc Capital Management
BlackRock
Susquehanna International
Renaissance Technologies
Goldman Sachs Group
Geode Capital Management
Jane Street

View all funds holding C4 Therapeutics